Israeli researchers develop smart sensors that guarantee the safety of vaccines

A study, led by Yftach Gepner, together with Dan Yamin and Erez Shmueli from Univ Tel Aviv University (TAU) develop an innovative device that improves the safety of vaccines.

The topic became particularly relevant because of the COVID-19 pandemic, in which the world needed vaccination fast and large, and in the process, concerns about their safety and their potential effects increased.

The Israeli TAU team used sensors, developed by the company Biobeat, based in Petah Tikva, which they placed on the chests of the participants, allowing them to measure 13 different physical parameters, including including heart and breathing rates, blood oxygen levels, temperature and blood pressure. .

The results showed that there was a significant difference between voluntarily reported side effects and objectively measured side effects. Many volunteers reported experiencing no reactions and experiencing physiological changes.

In addition, the study found that side effects peaked in the first 48 hours after vaccination, and then returned to levels measured before vaccine administration.

Gepner, from the Department of Epidemiology and Preventive Medicine at the Sackler School of Medicine, explained that “in most methods used today, clinical trials designed to evaluate the safety of a new drug or vaccine involve using self-report questionnaires, asking participants how they feel. before and after receiving the treatment.”